tm logo
LIPO-PAM
Live/Registered
REGISTERED

on 07 Mar 2023

Last Applicant/ Owned by

Serial Number

79317592 filed on 23rd Jun 2021

Registration Number

6993671 registered on 07th Mar 2023

in the Principal Register

Correspondent Address

Cynthia A. Moyer

Fredrikson & Byron, P.A.

Suite 4000

200 South Sixth Street

Minneapolis MN 55402

Filing Basis

No Filing Basis

Disclaimer

NO DATA

LIPO-PAM

The mark consists of the wording "LIPO-PAM" in black stylized font. The color black is claimed as a feature of the mark. Vaccines for cattle; oral vaccine preparations; veterinary vaccines; viral vaccines; vaccines; adjuvants for use with vaccines; vaccine preparations; Veterinary substances and preparations for treating and preventing viruses and other infectious diseases, inflammatory diseasesRead More

Classification Information


Class [005]
Pharmaceutical Products


Vaccines for cattle; oral vaccine preparations; veterinary vaccines; viral vaccines; vaccines; adjuvants for use with vaccines; vaccine preparations; Veterinary substances and preparations for treating and preventing viruses and other infectious diseases, inflammatory diseases, genetic diseases, neurological diseases, autoimmune diseases and cancer; human vaccine preparations; anti-microbial preparations for treating and preventing viruses and other infectious diseases; pharmaceutical preparations for treating and preventing viruses and other infectious diseases, inflammatory diseases, genetic diseases, neurological diseases, autoimmune diseases, and cancer; pharmaceutical compositions for the treatment and prevention of viruses and other infectious diseases, inflammatory diseases, genetic diseases, neurological diseases, autoimmune diseases, and cancer; reagents for medical use; diagnostic reagents for medical use for immunization diseases; diagnostic reagents for medical or veterinary purposes; clinical diagnostic reagents for medical use; preparations of microorganisms for medical or veterinary use; hepatitis vaccine; preparations for treatment of hepatitis; vaccines against flu; immunostimulants; immunomodulators; pharmaceutical preparations for the prevention of disorders of the immune system; pharmaceutical preparations for the prevention of diseases of the immune system; pharmaceutical preparations for regulating the immune system; pharmaceutical products for the treatment of viral diseases; veterinary vaccines for bovine animals; veterinary vaccines for sheep; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; pharmaceutical products for the treatment of cancer; drug delivery agents in the form of aqueous particles that provide a controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of injectable, inhalable, intranasal, oral, sublingual, transdermal and topical compositions that facilitate the delivery of pharmaceutical preparations; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the prevention of autoimmune disorders; pharmaceutical preparations for the prevention of autoimmune diseases; pharmaceutical preparations for the treatment of auto-immune diseases; pharmaceutical preparations for the treatment of immune system related diseases and disorders; anti-infectives; anti-viral agents; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for the treatment of tumours; biopharmaceuticals for the treatment of cancer; biological preparations for the treatment of cancer; compounds for treating cancer; pharmaceutical preparations and substances for the prevention of cancer

Mark Details


Serial Number

No 79317592

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 57428.0087

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Description of Design Search

The mark consists of the wording "LIPO-PAM" in black stylized font.

Legal History


Show more

Status DateAction Taken
08th Jun 2023FINAL DISPOSITION NOTICE SENT TO IB
08th Jun 2023FINAL DISPOSITION PROCESSED
07th Jun 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07th Mar 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
07th Mar 2023REGISTERED-PRINCIPAL REGISTER
06th Feb 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
18th Jan 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
18th Jan 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
21st Dec 2022NOTIFICATION PROCESSED BY IB
20th Dec 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED